Clinical Outcomes for Plasma-Based Comprehensive Genomic Profiling Versus Standard-of-Care Tissue Testing in Advanced Non–Small Cell Lung Cancer-Reference-Cited by-同舟云学术

Clinical Outcomes for Plasma-Based Comprehensive Genomic Profiling Versus Standard-of-Care Tissue Testing in Advanced Non–Small Cell Lung Cancer

Published:2022-01 Issue:1 Volume:23 Page:72-81
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Page Ray D.,Drusbosky Leylah M.,Dada Hiba,Raymond Victoria M.,Daniel Davey B.,Divers Stephen G.,Reckamp Karen L.^ORCID,Villalona-Calero Miguel A.,Dix Daniel,Odegaard Justin I.,Lanman Richard B.,Papadimitrakopoulou Vassiliki A.,Leighl Natasha B.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference37 articles.

1. Crizotinib versus chemotherapy in advanced ALK-positive lung cancer;Shaw;N Engl J Med,2013

2. Crizotinib in ROS1-rearranged non–small-cell lung cancer;Shaw;N Engl J Med,2014

3. First-line crizotinib versus chemotherapy in ALK-positive lung cancer;Solomon;N Engl J Med,2014

4. Targeted therapy for non-small cell lung cancer: current standards and the promise of the future;Chan;Transl Lung Cancer Res,2015

5. Immunotherapy in advanced lung cancer [Internet];Reckamp;Cancer Network,2020

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical application of the lung cancer compact PanelTM using various types of cytological specimens in patients with lung cancer;Lung Cancer;2024-02

2. Rapid and reliable testing for clinically actionable EGFR mutations in non-small cell lung cancer using the Idylla ^TM platform: a real-world two-center experience in Greece;Expert Review of Molecular Diagnostics;2024-01-09

3. A Phase 2 Single-Arm Study of Osimertinib for Radiotherapy-Naive Central Nervous System Metastasis NSCLC: Results for the First-Line Cohort of the OCEAN Study (LOGIK 1603/WJOG 9116L);JTO Clinical and Research Reports;2023-12

4. “Plasma-first” approach for molecular genotyping in non-small cell lung cancer: A narrative review;The Journal of Liquid Biopsy;2023-12

5. Matched tissue and liquid biopsies for advanced non-small cell lung cancer patients A potentially indispensable complementary approach;Translational Oncology;2023-09